Fortitude Family Office’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.9K Sell
216
-33
-13% -$2.66K ﹤0.01% 585
2026
Q1
$21.6K Sell
249
-139
-36% -$13.3K ﹤0.01% 415
2025
Q4
$37.3K Buy
388
+267
+221% +$25.9K 0.01% 285
2025
Q3
$11.5K Buy
121
+8
+7% +$735 ﹤0.01% 517
2025
Q2
$9.85K Sell
113
-226
-67% -$19.2K ﹤0.01% 561
2025
Q1
$30.5K Sell
339
-76
-18% -$6.8K 0.01% 314
2024
Q4
$33.1K Buy
415
+117
+39% +$10.1K 0.01% 346
2024
Q3
$26.8K Buy
+298
New +$25.1K 0.01% 356
2024
Q1
Sell
-301
Closed -$25.7K 1043
2023
Q4
$24.8K Buy
+301
New +$22.9K 0.02% 262

Other funds holding MDT

Fortitude Family Office's MDT Position: Q2 2026 in Review

Fortitude Family Office reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $2.66K and leaving 216 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #585.

Fortitude Family Office first reported a position in MDT in Q4 2023 and has held it in 9 quarters since. The position peaked at $37.3K in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fortitude Family Office held 216 shares of Medtronic worth $16.9K as of Q2 2026.
  • Fortitude Family Office sold 33 Medtronic shares in Q2 2026, an estimated $2.66K.
  • Medtronic made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #585 holding.
  • Fortitude Family Office first reported a position in Medtronic in Q4 2023 and has held it in 9 quarters since.
  • Fortitude Family Office's Medtronic position peaked at $37.3K in Q4 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.